HEALTHglobal
STAT+: How ARPA-H is developing FDA-authorized AI agents, tested in clinical trials
Single source
Updated 3 hours ago
First seen March 19, 2026 04:15:46Stay on top of this story
Follow the names and topics behind it.
Add this story's key topics to your watchlist so LyscoNews can highlight related developments and future matches.
Create a free account to sync your watchlist, saved stories, and alerts across devices.
Quick Summary
STAT's AI Prognosis takes a closer look at how the U.S. moonshot agency for health research is developing AI agents for deployment in hospitals.